Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicamen OrganicsNSE:MEDIORG +4.80%21 Days Payable is 210.58 as of Mar. 2026, which is 25% above its 10-year median of 168.16. GuruFocus rates NSE:MEDIORG with a GF Score™ of 21/100. The stock has 11 warning signs investors should review. Among 925 Drug Manufacturers companies, Medicamen Organics ranks better than 93.84% on this metric.
The historical rank and industry rank for Medicamen Organics's Days Payable or its related term are showing as below:
NSE:MEDIORG'
s Days Payable Range Over the Past 10 Years
Min: 136.5 Med: 168.16 Max: 421.17
Current: 421.17
During the past 6 years, Medicamen Organics's highest Days Payable was 421.17. The lowest was 136.50. And the median was 168.16.
NSE:MEDIORG's Days Payable is ranked better than 93.84% of 925
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs NSE:MEDIORG: 421.17
Medicamen Organics's Days Payable
increased
from Mar. 2024 (155.66) to Mar. 2026 (210.58).
It may suggest that Medicamen Organicsdelayed paying its suppliers.
Medicamen Organics Days Payable Related Terms
Medicamen Organics Days Payable Historical Data
* Premium members only.
The historical data trend for Medicamen Organics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicamen Organics Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Days Payable distribution charts can be found below:
* The bar in red indicates where Medicamen Organics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medicamen Organics's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicamen Organics (NSE:MEDIORG) has a Days Payable of 210.58 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicamen Organics and its competitors. This is 25% above median its historical median of 168.16. Over the past decade, Medicamen Organics' Days Payable has ranged from 136.50 to 421.17. According to the industry distribution chart, Medicamen Organics ranks #57 out of 925 companies in the Drug Manufacturers industry, placing it in the top 6.2%.
Is Medicamen Organics' Days Payable too high?
Medicamen Organics' current Days Payable of 210.58 is 25% above median its 10-year median of 168.16. Over the past 10 years, this metric has ranged from a low of 136.50 to a high of 421.17. The Drug Manufacturers industry median Days Payable is 90.38. Medicamen Organics' value of 210.58 is 133% above this industry median. Based on the distribution chart, Medicamen Organics ranks #57 out of 925 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Medicamen Organics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medicamen Organics ranks #57 out of 925 companies for Days Payable. This places Medicamen Organics in the top 6% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.38. Medicamen Organics' value of 210.58 is 133% above this benchmark. Historically, Medicamen Organics' own Days Payable has ranged from 136.50 to 421.17 over the past decade. While the company's 10-year median is 168.16 vs. the industry median of 90.38, Medicamen Organics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicamen Organics's current Days Payable of 210.58 is 133% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicamen Organics and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicamen Organics's current Days Payable is 210.58, which is 25% above median its own 10-year median of 168.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current Days Payable of 210.58. The current Days Payable is 210.58, which is 25% above median its 10-year median of 168.16 and 133% above the Drug Manufacturers industry median of 90.38. Medicamen Organics' overall GF Score™ is 21/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current Days Payable is 210.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
21GF Score
Get the complete analysis for NSE:MEDIORG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDIORG has been successfully added to your 
